Publicaciones (263) Publicaciones de Jose Maria Moraleda Jimenez

2024

  1. Optimizing cryopreservation conditions for use of fucosylated human mesenchymal stromal cells in anti-inflammatory/immunomodulatory therapeutics

    Frontiers in Immunology, Vol. 15

  2. The nuclei of human adult stem cells can move within the cell and generate cellular protrusions to contact other cells

    Stem cell research & therapy, Vol. 15, Núm. 1, pp. 32

2023

  1. Amniotic Membrane Restores Chronic Wound Features to Normal in a Keratinocyte TGF-β-Chronified Cell Model

    International Journal of Molecular Sciences, Vol. 24, Núm. 7

  2. Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT

    Bone Marrow Transplantation, Vol. 58, Núm. 11, pp. 1182-1188

  3. Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study

    The Lancet Oncology, Vol. 24, Núm. 8, pp. 913-924

  4. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance

    Nature Communications, Vol. 14, Núm. 1

  5. N-Acetylcistein for thrombotic thrombocytopenic purpura: an observational case series study

    Annals of Hematology, Vol. 102, Núm. 8, pp. 2069-2075

  6. Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)

    Bone Marrow Transplantation

  7. Therapeutic effect of adipose-derived mesenchymal stem cells in a porcine model of abdominal sepsis

    Stem Cell Research and Therapy, Vol. 14, Núm. 1

2022

  1. A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results

    Leukemia and Lymphoma, Vol. 63, Núm. 1, pp. 93-100

  2. Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study

    Haematologica, Vol. 107, Núm. 11, pp. 2675-2684

  3. Binucleated human bone marrow-derived mesenchymal cells can be formed during neural-like differentiation with independence of any cell fusion events

    Scientific Reports, Vol. 12, Núm. 1

  4. Case Report: α-Spectrin Mutation Associated with αLELY Polymorphism Responsible for Hereditary Pyropoikilocytosis

    Hematology Reports, Vol. 14, Núm. 4, pp. 300-304

  5. Chaperone-Mediated Autophagy Ablation in Pericytes Reveals New Glioblastoma Prognostic Markers and Efficient Treatment Against Tumor Progression

    Frontiers in Cell and Developmental Biology, Vol. 10

  6. Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes

    Shock (Augusta, Ga.), Vol. 57, Núm. 1, pp. 95-105

  7. Enforced mesenchymal stem cell tissue colonization counteracts immunopathology

    npj Regenerative Medicine, Vol. 7, Núm. 1

  8. Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications

    Histopathology, Vol. 81, Núm. 6, pp. 826-840

  9. Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort

    Journal of Allergy and Clinical Immunology, Vol. 149, Núm. 5, pp. 1744-1754.e8

  10. Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma

    Blood Advances, Vol. 6, Núm. 11, pp. 3234-3239

  11. New Insights Into Pathophysiology of β-Thalassemia

    Frontiers in Medicine, Vol. 9